Target intelligence / Profile preview

Protein phosphatase (PP (generic; specific isoforms include PP1, PP2A, PP2B, etc.))

Target
PP (generic; specific isoforms include PP1, PP2A, PP2B, etc.)
Molecular classification
Enzyme, Hydrolase, Phosphatase, Serine/threonine phosphatase, Tyrosine phosphatase, Protein phosphatase family (PPP, PPM, Asp-based, PTP)
01

Overview

Protein phosphatase refers to a large superfamily of enzymes that catalyze the removal of a phosphate group from phosphorylated proteins—a critical process for the regulation of cellular signaling. Protein phosphatases counterbalance the actions of protein kinases, maintaining cell homeostasis through reversible phosphorylation. They are broadly classified by substrate specificity and structural features into serine/threonine phosphatases (PPP, PPM, Asp-based), tyrosine phosphatases (PTP), and dual-specific phosphatases. Prominent members include protein phosphatase 1 (PP1), protein phosphatase 2A (PP2A), protein phosphatase 2B (calcineurin/PP2B), and protein phosphatase 2C (PP2C/PPM1). They play essential roles in cell cycle progression, apoptosis, cell signaling, and stress responses. Dysfunction or dysregulation of specific protein phosphatases is implicated in cancer, neurodegeneration, cardiovascular diseases, and other pathologies[1][3][5]. Due to their central roles, select protein phosphatases—especially calcineurin—are important drug targets (e.g., by immunosuppressants such as cyclosporine and tacrolimus), but the broad and highly conserved nature of these enzyme families poses challenges for therapeutic specificity and safety[3][5][8]. **Important caveat:** "Protein phosphatase" as a target is a superfamily name and lacks specificity. Research, clinical targeting, and biomarker applications typically relate to individual isoforms (e.g., PP2A, PP1, calcineurin/PP2B, PPM1D), each with distinct biology and pharmacology. Therefore, this entry is too general for drug development or biomarker strategies. A more specific target, such as "Protein phosphatase 2A," should be used for structured annotation or therapeutic purposes[1][2][4][6].

Other names
phosphoprotein phosphataseserine/threonine phosphatasetyrosine phosphataseprotein phosphatase 1 (PP1)protein phosphatase 2A (PP2A)protein phosphatase 2B (PP2B/calcineurin)protein phosphatase 2C (PP2C)PPM1PPP
02

Mechanism of action

Inhibition of phosphatase activity (immunosuppression by calcineurin inhibition, toxin-induced phosphatase inhibition, etc.) Modulation of cell signaling by altering protein phosphorylation state

03

Biological functions

Signal transductionCell cycle regulationApoptosisImmune responseCell proliferationCell deathCellular stress responseGene expression regulation
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationOther (dysregulation implicated in various diseases)
05

Safety considerations

Broad inhibition can lead to off-target effects (immunosuppression, toxicity)Specificity is challenging due to many isoforms and complex regulatory subunitsDysregulation associated with oncogenesis, neurological dysfunction, and metabolic diseases
06

Interacting drugs

Cyclosporine (targets calcineurin/PP2B)

3 more in the full profile.

07

Biomarkers

Phosphorylation state of signaling proteins (e.g., assessment of PP2A activity via substrate dephosphorylation in cancer research)Expression or mutation status of specific phosphatase subunits (e.g., PPM1D mutations in tumors)

Beyond the preview

Go deeper on Protein phosphatase (PP (generic; specific isoforms include PP1, PP2A, PP2B, etc.)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein phosphatase (PP (generic; specific isoforms include PP1, PP2A, PP2B, etc.)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call